ProPhase Labs (NASDAQ: PRPH) reported Q2 EPS of ($0.20), $0.06 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $13.22 million versus the consensus estimate of $14.14 million.

For earnings history and earnings-related data on ProPhase Labs (PRPH) click here.